GlassScriptPhysician profile
Amelia Schroeder
NPI 1720694771
$11,368.60
in general payments reported to CMS, 2019-2025
34 companies · $4,040 in 2025
The $4,040 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,827 · 2022: $1,583 · 2023: $2,019 · 2024: $1,900 · 2025: $4,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,967 · Travel and Lodging: $714 · Education: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,966.85 |
| Travel and Lodging | $714.02 |
| Education | $278.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,531.20 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Inspire Medical Systems, INC. | $1,364.86 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,306.26 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $591.51 | 2021-2025 | Ofev, Jascayd |
| United Therapeutics Corporation | $544.47 | 2021-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $518.36 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $433.83 | 2021-2024 | |
| Mylan Specialty L.P. | $402.91 | 2021-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $389.73 | 2023-2025 | Uptravi, Opsumit |
| Avadel Cns Pharmaceuticals, LLC | $360.00 | 2023-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $315.85 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $310.19 | 2024-2025 | Purified Cortrophin Gel |
| Regeneron Healthcare Solutions, INC. | $300.20 | 2021-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $234.44 | 2023-2025 | Glassia |
| Viatris Specialty LLC | $182.56 | 2025 | Yupelri |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $163.41 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $152.48 | 2021-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $149.91 | 2021 | |
| Harmony Biosciences LLC | $142.30 | 2023-2025 | Wakix |
| Philips North America LLC | $114.32 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Amgen INC. | $109.08 | 2023-2025 | Tezspire |
| Insmed, INC. | $106.76 | 2021-2025 | Arikayce, Brinsupri |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.71 | 2022 | |
| Chiesi USA, INC. | $79.46 | 2022-2025 | Cleviprex, Kengreal |
| Pulmonx Corporation | $67.96 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Axsome Therapeutics, INC. | $66.12 | 2023-2025 | Sunosi |
| Intuitive Surgical, INC. | $64.30 | 2023 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $52.23 | 2021-2025 | Winrevair |
| Pfizer INC. | $38.26 | 2024 | |
| Idorsia Pharmaceuticals US INC | $30.99 | 2023-2024 | Quviviq |
| Advanced Respiratory, INC | $28.14 | 2021 | |
| Verona Pharma, INC. | $18.08 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $13.73 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amelia Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.